Explore more publications!

OneWell Health Care Receives California Title 22 Approval With Zero Deficiencies

OneWell Health Care Receives California Title 22 Approval With Zero Deficiencies

OneWell Health Care Contact Information - California

OneWell of California LLC Authorized to Provide Licensed Home Health Services in California California Home Health Agency | Title 22 Approved | December 2025

The Title 22 approval allows us to expand licensed home health services across California while continuing to deliver high-quality, compliant, and patient-centered care.”
— Aytekin Oldac, Founder & CEO of OneWell Health Care.

SAN DIEGO, CA, UNITED STATES, December 16, 2025 /EINPresswire.com/ -- OneWell Health Care announced today that OneWell of California LLC has received full California Title 22 approval with zero deficiencies, following a state survey conducted on July 9, 2025.

The California Department of Public Health (CDPH) confirmed that OneWell of California is fully compliant with the California Code of Regulations, Title 22, Division 5, Chapter 6, the regulatory framework governing licensed home health agencies in California. No deficiencies were cited.

With this approval, OneWell of California LLC is now authorized to provide the following home health services throughout California:

● Skilled Nursing
● Physical Therapy
● Occupational Therapy
● Speech Therapy
● Medical Social Work
● Home Health Aide

Achieving Title 22 home health approval with zero deficiencies is a significant milestone in California’s highly regulated healthcare environment and demonstrates OneWell’s commitment to compliance, clinical quality, and operational excellence.

Nevin Dursun
OneWell Health Care
+1 855-720-9355
info@onewell.org
Visit us on social media:
LinkedIn
Instagram
Facebook
YouTube
X

Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions